Oxymetazoline - Aclaris Therapeutics
At a glance
- Drug Originator Vicept Therapeutics
- Drug Licenced by Mayne Pharma; Sato
- Drug Class Eye disorder therapies; Imidazoles; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor agonists
- USA Patent Applicants MAYNE PHARMA
- USA Patents 10
- NDAs 1
- International Patents 23
- Patent Applications 2,096

Disclaimer